An Evening With the Experts: Discussion on the Evolving Immunotherapy Paradigm for Non-Small-Cell Lung Cancer

Download this slideset from a live CCO symposium for an expert overview of the evolving immunotherapy landscape for advanced or metastatic NSCLC.

Julie Brahmer, MD, MSc Released: June 7, 2022

Download this slideset from a live CCO symposium for an expert overview of the evolving immunotherapy landscape for early-stage resectable and stage III unresectable NSCLC.

Natasha Leighl, MD, MMSC, FRCPC, FASCO Released: June 7, 2022

Download this slideset from a live CCO symposium for an expert overview of data informing optimal use of immunotherapy in the treatment of special patient populations, including those with autoimmune disease, CNS metastases, or poor performance status, along with highlights of immunotherapy combination regimens under investigation.

Jarushka Naidoo, MB BCH BAO, MHS Released: June 7, 2022

In this on-demand webcast from a live symposium, oncology experts Julie Brahmer, MD; Natasha B. Leighl, MD; and Jarushka Naidoo, MB BCH BAO, MHS discuss the latest clinical data informing optimal use of immunotherapy across the spectrum of NSCLC in the context of patient cases.

Julie Brahmer, MD, MSc
Program Director Natasha Leighl, MD, MMSC, FRCPC, FASCO Jarushka Naidoo, MB BCH BAO, MHS Physicians: maximum of 1.75 AMA PRA Category 1 Credits™ Released: June 7, 2022 Expired: June 6, 2023